Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease | Biomarkers in Medicine
Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis | PLOS ONE
Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease | Biomarkers in Medicine
CSF markers for incipient Alzheimer's disease - ScienceDirect
Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease | Nature Medicine
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ? | Alzheimer's Research & Therapy | Full Text
![PDF] CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/02efe2abec13a309916c6860de5ad8a8a096fe5d/5-Table3-1.png "PDF] CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. | Semantic Scholar")
PDF] CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. | Semantic Scholar
Biomarkers for Alzheimer's disease: current status and prospects for the future - Blennow - 2018 - Journal of Internal Medicine - Wiley Online Library
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected | EMBO Molecular Medicine
Variability of CSF Alzheimer's Disease Biomarkers: Implications for Clinical Practice | PLOS ONE
JPM | Free Full-Text | Current Biomarkers for Alzheimer's Disease: From CSF to Blood | HTML
CSF markers for incipient Alzheimer's disease - ScienceDirect
Biomarkers for Alzheimer's disease: current status and prospects for the future - Blennow - 2018 - Journal of Internal Medicine - Wiley Online Library
Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease? | Semantic Scholar
![PDF] CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9751bfbee05ddb1b0f7d381c556813746cdc7b4e/26-Table1-1.png "PDF] CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients | Semantic Scholar")
PDF] CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients | Semantic Scholar
![PDF] CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/02efe2abec13a309916c6860de5ad8a8a096fe5d/4-Table2-1.png "PDF] CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. | Semantic Scholar")
PDF] CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. | Semantic Scholar
Clinical significance of fluid biomarkers in Alzheimer's Disease | SpringerLink
Practice
Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression | Scientific Reports
![PDF] CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/02efe2abec13a309916c6860de5ad8a8a096fe5d/7-Figure3-1.png "PDF] CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. | Semantic Scholar")
PDF] CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. | Semantic Scholar
CSF markers for incipient Alzheimer's disease - ScienceDirect
Establishment of combined diagnostic models of Alzheimer's disease in a Chinese cohort: the Chongqing Ageing & Dementia Study (CADS) | Translational Psychiatry
Advances in the development of new biomarkers for Alzheimer's disease | Translational Neurodegeneration | Full Text
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study - The Lancet Neurology
